WeedWeek edition / March 04, 2022

Still a long way off though

WeedWeek Newsletter Archive
WeedWeek edition
02/28/22
MedMen exits Florida in $83M deal
WeedWeek edition
02/25/22
MSOs oppose Illinois equity bill
WeedWeek edition
02/17/22
Ascend calls MedMen cannabiz “pariah”
WeedWeek edition
02/14/22
New York bill could accelerate REC access
WeedWeek edition
02/10/22
N.Y. cracks down on gray market
WeedWeek edition
02/08/22
NY Gov resists MedMen subpoena
WeedWeek edition
02/03/22
How to save cannabis equity
WeedWeek edition
01/31/22
Three cannabiz court cases to watch
WeedWeek edition
01/28/22
Amazon endorses GOP legalization bill
WeedWeek edition
01/25/22
MedMen countersues Ascend over broken N.Y. deal
WeedWeek edition
01/20/22
MedMen founder Bierman tells his story
WeedWeek edition
01/17/22
Ascend sues MedMen over broken N.Y. deal
WeedWeek edition
01/13/22
California biz rallies in Sacramento
WeedWeek edition
01/11/22
Budweiser-maker and Tilray break up
WeedWeek edition
01/07/22
MedMen / Ascend dispute escalates
WeedWeek edition
01/04/22
MedMen terminates N.Y. deal with Ascend
WeedWeek edition
12/27/21
WeedWeek’s cannabiz predictions for 2022
WeedWeek edition
12/21/21
Ten biggest weed stories of 2021
WeedWeek edition
12/17/21
Market collapse “imminent,” California biz warns
WeedWeek edition
12/13/21
How MSOs evaluate brands
WeedWeek edition
12/10/21
Five takeaways from Hall of Flowers
WeedWeek edition
12/07/21
Jushi thinks corporate weed can be cool
WeedWeek edition
12/03/21
SuperNet: A credit card for dispensaries
WeedWeek edition
11/29/21
Harborside to acquire Urbn Leaf and Loudpack